Who owns Cue Biopharma Inc?
- Ticker: CUE
- CUSIP Number: 22978p106
Tip: Access positions for across all investors
Analyze quarterly positions in Cue Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cue Biopharma stock
Who bought or sold Cue Biopharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bleichroeder | 6.8M | $4.9M | 0% | Sep 2025 |
|
| Catalytic Wealth RIA | 3.4M | $2.5M | 3% | Sep 2025 |
|
| Vanguard Group | 3.0M | $2.2M | -5% | Sep 2025 |
|
| Geode Capital Management | 801k | $576k | 16% | Sep 2025 |
|
| Boothbay Fund Management | 611k | $439k | 100% | Sep 2025 |
|
| Robertson Stephens Wealth Management | 479k | $344k | 0% | Sep 2025 |
|
| BlackRock | 449k | $323k | 0% | Sep 2025 |
|
| Advisory Research | 257k | $185k | 0% | Sep 2025 |
|
| Renaissance Technologies | 227k | $163k | 70% | Sep 2025 |
|
| UBS Group | 199k | $143k | -32% | Sep 2025 |
|
| Stifel Financial | 197k | $141k | 0% | Sep 2025 |
|
| State Street Corporation | 190k | $136k | 0% | Sep 2025 |
|
| Susquehanna International | 167k | $120k | 8% | Sep 2025 |
|
| Angeles Wealth Management | 120k | $86k | 0% | Sep 2025 |
|
| Northern Trust | 101k | $73k | -24% | Sep 2025 |
|
| Chicago Partners Investment | 86k | $64k | -3% | Sep 2025 |
|
| Squarepoint Ops | 86k | $62k | 100% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 80k | $57k | -4% | Sep 2025 |
|
| Sigma Planning | 53k | $38k | -4% | Sep 2025 |
|
| LPL Financial | 46k | $33k | -22% | Sep 2025 |
|
| Two Sigma Securities | 40k | $28k | 100% | Sep 2025 |
|
| Texas Capital Bank Wealth Management Services | 33k | $24k | 0% | Sep 2025 |
|
| Morgan Stanley | 30k | $20k | 100% | Jun 2025 |
|
| Navalign | 25k | $18k | 0% | Sep 2025 |
|
| Cambridge Investment Research Advisors | 20k | $14k | 0% | Sep 2025 |
|
| Goss Wealth Management | 20k | $14k | 0% | Sep 2025 |
|
| Wells Fargo & Company | 20k | $14k | 0% | Sep 2025 |
|
| Prevail Innovative Wealth Advisors | 19k | $14k | 0% | Sep 2025 |
|
| Virtu Financial | 15k | $11k | -27% | Sep 2025 |
|
| XTX Topco | 15k | $11k | -34% | Sep 2025 |
|
| Goldman Sachs Group | 14k | $10k | 0% | Sep 2025 |
|
| Tower Research Capital | 10k | $7.3k | 100% | Sep 2025 |
|
| SeaCrest Wealth Management | 10k | $8.6k | -23% | Sep 2025 |
|
| Barclays | 6.0k | $4.3k | 0% | Sep 2025 |
|
| Gleason Group | 6.0k | $4.3k | 0% | Sep 2025 |
|
| Simplex Trading | 4.8k | $3.0k | 100% | Sep 2025 |
|
| Newbridge Financial Services Group | 3.0k | $2.2k | 0% | Sep 2025 |
|
| Golden State Wealth Management | 2.0k | $1.4k | 0% | Sep 2025 |
|
| Tidemark | 1.5k | $1.1k | 0% | Sep 2025 |
|
| UMA Financial Services | 1.0k | $724.018200 | 0% | Sep 2025 |
|
| Mather Group | 1.0k | $719.000000 | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 904.00 | $649.976000 | -14% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 690.00 | $495.972000 | -3% | Sep 2025 |
|
| Advisor Group Holdings | 680.00 | $489.600000 | 0% | Sep 2025 |
|
| MAI Wealth Advisors | 350.00 | $252.000000 | 0% | Sep 2025 |
|
| Sunbelt Securities | 237.00 | $170.000100 | 0% | Sep 2025 |
|
| Advisory Services Network | 200.00 | $144.000000 | 100% | Sep 2025 |
|
| Armstrong Advisory Group | 120.00 | $87.000000 | 0% | Sep 2025 |
|
| IFP Advisors | 100.00 | $72.000000 | 0% | Sep 2025 |
|
| SBI Securities | 1.00 | $1.000000 | 100% | Sep 2025 |
|
Who sold out of Cue Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Salzhauer Michael | Jun 2025 | 16k | $11k |
| Hrt Financial | Jun 2025 | 12k | $8.0k |
| Beacon Pointe Advisors | Jun 2025 | 10k | $6.8k |
| Raymond James Financial | Jun 2025 | 3.4k | $2.3k |